Search
Search Results
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2009]
- Subject(s):
- Comparative Effectiveness Research
Cost-Benefit Analysis
Decision Making
Insurance Coverage
Insurance, Health -- economics
Leadership
Medicare
Outcome Assessment (Health Care)
Public Opinion
Humans
California
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2009]
- Subject(s):
- Comparative Effectiveness Research
Health Care Reform -- economics
Insurance Coverage -- economics
Medicaid -- economics
Primary Health Care -- economics
Community Health Centers -- economics
Community Health Services -- economics
Medicare -- economics
Public Health -- economics
Reimbursement, Disproportionate Share -- economics
Research -- economics
Taxes
Telemedicine -- economics
Humans
California
United States. Indian Health Service.
United States.
United States.
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 17, 2017
- Subject(s):
- Anabolic Agents -- therapeutic use
Antibodies, Monoclonal, Humanized -- therapeutic use
Osteoporosis, Postmenopausal -- drug therapy
Parathyroid Hormone-Related Protein -- therapeutic use
Anabolic Agents -- adverse effects
Anabolic Agents -- economics
Antibodies, Monoclonal, Humanized -- adverse effects
Antibodies, Monoclonal, Humanized -- economics
Bone Density Conservation Agents -- adverse effects
Bone Density Conservation Agents -- economics
Bone Density Conservation Agents -- therapeutic use
Comparative Effectiveness Research
Diphosphonates -- adverse effects
Diphosphonates -- economics
Diphosphonates -- therapeutic use
Osteoporotic Fractures -- prevention & control
Parathyroid Hormone-Related Protein -- adverse effects
Parathyroid Hormone-Related Protein -- economics
Randomized Controlled Trials as Topic
Teriparatide -- adverse effects
Teriparatide -- economics
Teriparatide -- therapeutic use
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
- Subject(s):
- Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
- Subject(s):
- Ovarian Neoplasms -- drug therapy
Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
Comparative Effectiveness Research
Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
Poly(ADP-ribose) Polymerase Inhibitors -- economics
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 6, 2017
- Subject(s):
- Chronic Pain -- therapy
Cognitive Therapy
Low Back Pain -- therapy
Mind-Body Therapies
Neck Pain -- therapy
Acupuncture Therapy -- economics
Comparative Effectiveness Research
Mindfulness -- economics
Tai Ji -- economics
Treatment Outcome
Yoga
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2017
- Subject(s):
- Membrane Transport Modulators -- therapeutic use
Tardive Dyskinesia -- drug therapy
Vesicular Monoamine Transport Proteins -- antagonists & inhibitors
Antipsychotic Agents -- adverse effects
Comparative Effectiveness Research
Membrane Transport Modulators -- adverse effects
Membrane Transport Modulators -- economics
Tardive Dyskinesia -- chemically induced
Humans
United States
- Author(s):
- Emond, Sarah K., author
Reed, Sarah Jane, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, [2013]
- Subject(s):
- Outcome Assessment (Health Care) -- economics
Prostatic Neoplasms -- prevention & control
Prostatic Neoplasms -- therapy
Reimbursement Mechanisms -- economics
Comparative Effectiveness Research
Health Care Reform -- economics
Current Procedural Terminology
Pilot Projects
Program Evaluation
Quality Indicators, Health Care -- classification
Recurrence
Surveys and Questionnaires
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, July 2014
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 2014
- Subject(s):
- Comparative Effectiveness Research
Diabetes Mellitus, Type 2 -- drug therapy
Disease Management
Blood Glucose -- analysis
Blood Glucose -- metabolism
Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
Drug Therapy, Combination
Hemoglobin A, Glycosylated -- analysis
Hypoglycemic Agents -- administration & dosage
Hypoglycemic Agents -- therapeutic use
Insulin -- therapeutic use
Metformin -- administration & dosage
Metformin -- therapeutic use
Monitoring, Ambulatory
Randomized Controlled Trials as Topic
Receptors, Glucagon -- agonists
Sulfonylurea Compounds -- administration & dosage
Sulfonylurea Compounds -- therapeutic use
Treatment Outcome
Humans
New England
United States
- Author(s):
- Cunningham, Courtney, author
Trevers, Karin, author
Chapman, Rick, author
Loos, Anne, author
Lawler, Erin, author
Liu, Shanshan, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, April 27, 2016
- Subject(s):
- Ambulatory Care -- organization & administration
Comparative Effectiveness Research
Palliative Care -- organization & administration
Anxiety -- therapy
Caregivers
Clinical Trials as Topic
Cost Savings
Cost-Benefit Analysis
Depression -- therapy
Health Policy
Health Resources -- utilization
Health Services Accessibility
Healthcare Disparities
Insurance, Health, Reimbursement
Medicaid -- economics
Medicare -- economics
Outcome Assessment (Health Care)
Palliative Care -- manpower
Patient Education as Topic
Patient Satisfaction
Quality of Life
Research
Spirituality
Humans
United States
- Author(s):
- Pearson, Steven D., author
Banken, Reiner, author
Chapman, Rick, author
Russo, Elizabeth T., author
Loos, Anne M., author
Emond, Sarah K., author
Segel, Celia S., author
Ollendorf, Daniel A., author
Chhatwal, Jagpreet, author
Hur, Chin, author
Klebanoff, Matthew, author
Samur, Sumeyye K., author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, July 26, 2016
- Subject(s):
- Bile Acids and Salts -- agonists
Comparative Effectiveness Research
Fatty Liver -- drug therapy
Bile Acids and Salts -- adverse effects
Diabetes Mellitus, Type 2
Dyslipidemias
Liver Cirrhosis -- prevention & control
Quality of Life
Randomized Controlled Trials as Topic
Humans
United States
- Author(s):
- Pearson, Steven D., author
Banken, Reiner, author
Chapman, Rick, author
Emond, Sarah K., author
Loos, Anne M., author
Russo, Elizabeth T., author
Segel, Celia S., author
Ollendorf, Daniel A., author
Chhatwal, Jagpreet, author
Hur, Chin, author
Klebanoff, Matthew, author
Samur, Sumeyye, author
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 2016
- Subject(s):
- Bile Acids and Salts -- agonists
Cholangitis -- drug therapy
Comparative Effectiveness Research
Value-Based Purchasing
Benchmarking
Bile Acids and Salts -- adverse effects
Bile Acids and Salts -- economics
Cost-Benefit Analysis
Liver Cirrhosis -- prevention & control
Liver Transplantation
Pruritus
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, December 2 2016
- Subject(s):
- Comparative Effectiveness Research
Immunologic Factors -- therapeutic use
Psoriasis -- drug therapy
Adalimumab -- therapeutic use
Benchmarking
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Interleukin-12 -- antagonists & inhibitors
Interleukin-17
Interleukin-23 -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors
Phototherapy
Psoriasis -- immunology
Psoriasis -- therapy
Randomized Controlled Trials as Topic
Severity of Illness Index
Tumor Necrosis Factor-alpha -- antagonists & inhibitors
Ustekinumab -- therapeutic use
Value-Based Purchasing
Humans
United States
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 6, 2017
- Subject(s):
- Comparative Effectiveness Research
Multiple Sclerosis, Chronic Progressive -- drug therapy
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- economics
Antirheumatic Agents -- therapeutic use
Benchmarking
Cost-Benefit Analysis
Immunosuppressive Agents -- adverse effects
Immunosuppressive Agents -- economics
Immunosuppressive Agents -- therapeutic use
Insurance Coverage
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 10, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Comparative Effectiveness Research
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Immunologic Factors -- economics
Immunotherapy
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Protein Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Treatment Outcome
Tumor Necrosis Factor-alpha -- antagonists & inhibitors
Value-Based Purchasing
Humans
United States
- Author(s):
- Ollendorf, Daniel A., author
Shore, Karen K., author
Cameron, Chris, author
Weissberg, Jed, author
Loos, Anne M., author
Synnott, Patricia, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, August 10, 2015
- Subject(s):
- Disease Management
Obesity -- therapy
Anti-Obesity Agents
Bariatric Surgery -- economics
Bariatric Surgery -- statistics & numerical data
Body Mass Index
Comparative Effectiveness Research
Cost-Benefit Analysis
Insurance Coverage
Obesity -- complications
Obesity -- etiology
Obesity -- prevention & control
Practice Guidelines as Topic
Technology Assessment, Biomedical
Weight Loss
Humans
United States
- Author(s):
- Elitzer, Julia, author
Tatar, Margaret, author
- Publication:
- [Oakland, Calif.] : California Health Care Foundation, September 2017
- Subject(s):
- Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- prevention & control
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Cost Savings
Drug Overdose -- drug therapy
Drug Overdose -- prevention & control
Health Care Costs
Health Services Accessibility
Healthcare Disparities
Inappropriate Prescribing -- prevention & control
Insurance Coverage -- legislation & jurisprudence
Managed Care Programs
Medicaid
Mental Health Services -- legislation & jurisprudence
Methadone -- therapeutic use
Naloxone
Naltrexone -- therapeutic use
Neonatal Abstinence Syndrome -- drug therapy
Opioid-Related Disorders -- epidemiology
Patient Care Management
Prescription Drug Diversion
State Government
Humans
California
United States
- Publication:
- New York, NY : Commonwealth Fund, February 2009
- Subject(s):
- Health Care Reform
Insurance, Health
Benchmarking
Comparative Effectiveness Research
Financing, Personal
Health Benefit Plans, Employee
Health Care Reform -- economics
Health Care Reform -- statistics & numerical data
Health Care Reform -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Health Promotion
Health Services Accessibility -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Leadership
Medical Informatics
Medically Uninsured -- statistics & numerical data
Private Sector
Public Sector
Quality of Health Care
Humans
United States
